Tewari KS, Colombo N, Monk BJ, Dubot C, et al. Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer: Subgroup Analyses from the KEYNOTE-826 Randomized Clinical Trial. JAMA Oncol 2023 Dec 14. doi: 10.1001/jamaoncol.2023.5410.
PMID: 38095881